Дата канвертавання26.04.2016
Памер42.21 Kb.


Aaron, S.D., Vandemheen, K.L., Fergusson, D., Maltais, F., Bourbeau, J., Goldstein, R., Balter, M., O'Donnell, D., McIvor, A., Sharma, S., Bishop, G., Anthony, J., Cowie, R., Field, S., Hirsch, A., Hernandez, P., Rivington, R., Road, J., Hoffstein, V., Hodder, R., Marciniuk, D., McCormack, D., Fox, G., Cox, G., Prins, H.B., Ford, G., Bleskie, D., Doucette, S., Mayers, I., Chapman, K., Zamel, N., FitzGerald, M., 2007. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 146, 545-555.

Abboud, R.T., Vimalanathan, S., 2008. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 12, 361-367.

Abraham, G., Kottke, C., Dhein, S., Ungemach, F.R., 2006. Agonist-independent alteration in beta-adrenoceptor-G-protein-adenylate cyclase system in an equine model of recurrent airway obstruction. Pulm Pharmacol Ther 19, 218-229.

Adcock, I.M., Ito, K., 2005. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy. Proc Am Thorac Soc 2, 313-319; discussion 340-311.

Advenier, C., Qian, Y., Koune, J.D., Molimard, M., Candenas, M.L., Naline, E., 1992. Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig. Br J Pharmacol 105, 792-798.

Albaiceta, G.M., Gutierrez-Fernandez, A., Parra, D., Astudillo, A., Garcia-Prieto, E., Taboada, F., Fueyo, A., 2008. Lack of matrix metalloproteinase-9 worsens ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 294, L535-543.

Anderson, G.P., Linden, A., Rabe, K.F., 1994. Why are long-acting beta-adrenoceptor agonists long-acting? Eur Respir J 7, 569-578.

Anderson, R., Feldman, C., Theron, A.J., Ramafi, G., Cole, P.J., Wilson, R., 1996. Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro. Br J Pharmacol 117, 1387-1394.

Anelli, T., Mannello, F., Salani, M., Tonti, G.A., Poiana, G., Biagioni, S., 2007. Acetylcholine induces neurite outgrowth and modulates matrix metalloproteinase 2 and 9. Biochem Biophys Res Commun 362, 269-274.

Aoshiba, K., Yokohori, N., Nagai, A., 2003. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 28, 555-562.

Asano, K., Shikama, Y., Shibuya, Y., Nakajima, H., Kanai, K., Yamada, N., Suzaki, H., 2008. Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro. Int J Chron Obstruct Pulmon Dis 3, 781-789.

Balzano, G., Stefanelli, F., Iorio, C., De Felice, A., Melillo, E.M., Martucci, M., Melillo, G., 1999. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med 160, 1486-1492.

Baouz, S., Giron-Michel, J., Azzarone, B., Giuliani, M., Cagnoni, F., Olsson, S., Testi, R., Gabbiani, G., Canonica, G.W., 2005. Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB. Int Immunol 17, 1473-1481.

Baraldo, S., Bazzan, E., Zanin, M.E., Turato, G., Garbisa, S., Maestrelli, P., Papi, A., Miniati, M., Fabbri, L.M., Zuin, R., Saetta, M., 2007. Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression. Chest 132, 1733-1740.

Baraldo, S., Turato, G., Badin, C., Bazzan, E., Beghe, B., Zuin, R., Calabrese, F., Casoni, G., Maestrelli, P., Papi, A., Fabbri, L.M., Saetta, M., 2004. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax 59, 308-312.

Barbera, J.A., Peinado, V.I., Santos, S., 2003. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 21, 892-905.

Barnes, P.J., 2000. The pharmacological properties of tiotropium. Chest 117, 63S-66S.

Barnes, P.J., 2001. Tiotropium bromide. Expert opin Investig Drugs 10, 733-740.

Barnes, P.J., 2003. Chronic obstructive pulmonary disease * 12: New treatments for COPD. Thorax 58, 803-808.

Barnes, P.J., 2004. Alveolar macrophages as orchestrators of COPD. COPD 1, 59-70.

Barnes, P.J., 2008. Frontrunners in novel pharmacotherapy of COPD. Curr Opin Pharmacol 8, 300-307.

Barnes, P.J., Shapiro, S.D., Pauwels, R.A., 2003. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22, 672-688.

Battram, C., Charlton, S.J., Cuenoud, B., Dowling, M.R., Fairhurst, R.A., Farr, D., Fozard, J.R., Leighton-Davies, J.R., Lewis, C.A., McEvoy, L., Turner, R.J., Trifilieff, A., 2006. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quino lin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther 317, 762-770.

Belmonte, K.E., 2005. Cholinergic pathways in the lungs and anticholinergic therapy for chronic obstructive pulmonary disease. Proc Am Thorac Soc 2, 297-304; discussion 311-292.

Bernfeld, P., Homburger, F., Soto, E., Pai, K.J., 1979. Cigarette smoke inhalation studies in inbred Syrian golden hamsters. J Natl Cancer Inst 63, 675-689.

Betsuyaku, T., Nishimura, M., Takeyabu, K., Tanino, M., Venge, P., Xu, S., Kawakami, Y., 1999. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 159, 1985-1991.

Birrell, M.A., Wong, S., Hardaker, E.L., Catley, M.C., McCluskie, K., Collins, M., Haj-Yahia, S., Belvisi, M.G., 2006. IkappaB kinase-2-independent and -dependent inflammation in airway disease models: relevance of IKK-2 inhibition to the clinic. Mol Pharmacol 69, 1791-1800.

Bissonnette, E.Y., Befus, A.D., 1997. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells. J Allergy Clin Immunol 100, 825-831.

Bloemen, P.G., van den Tweel, M.C., Henricks, P.A., Engels, F., Kester, M.H., van de Loo, P.G., Blomjous, F.J., Nijkamp, F.P., 1997. Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am J Physiol 272, L580-587.

Bolognin, M., Kirschvink, N., Leemans, J., De Buscher, V., Snaps, F., Gustin, P., Peeters, D., Clercx, C., 2007. Characterisation of the acute and reversible airway inflammation induced by cadmium chloride inhalation in healthy dogs and evaluation of the effects of salbutamol and prednisolone. Vet J.

Bolton, P.B., Lefevre, P., McDonald, D.M., 1997. Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways. Am J Respir Crit Care Med 155, 1428-1435.

Bombini, G., Canetti, C., Rocha, F.A., Cunha, F.Q., 2004. Tumour necrosis factor-alpha mediates neutrophil migration to the knee synovial cavity during immune inflammation. Eur J Pharmacol 496, 197-204.

Bos, I.S., Gosens, R., Zuidhof, A.B., Schaafsma, D., Halayko, A.J., Meurs, H., Zaagsma, J., 2007. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 30, 653-661.

Boschetto, P., Quintavalle, S., Zeni, E., Leprotti, S., Potena, A., Ballerin, L., Papi, A., Palladini, G., Luisetti, M., Annovazzi, L., Iadarola, P., De Rosa, E., Fabbri, L.M., Mapp, C.E., 2006. Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax 61, 1037-1042.

Bowden, J.J., Sulakvelidze, I., McDonald, D.M., 1994. Inhibition of neutrophil and eosinophil adhesion to venules of rat trachea by beta 2-adrenergic agonist formoterol. J Appl Physiol 77, 397-405.

Bracke, K.R., D'Hulst A, I., Maes, T., Moerloose, K.B., Demedts, I.K., Lebecque, S., Joos, G.F., Brusselle, G.G., 2006. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 177, 4350-4359.

Brajer, B., Batura-Gabryel, H., Nowicka, A., Kuznar-Kaminska, B., Szczepanik, A., 2008. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. J Physiol Pharmacol 59 Suppl 6, 145-152.

Brass, D.M., Hollingsworth, J.W., Cinque, M., Li, Z., Potts, E., Toloza, E., Foster, W.M., Schwartz, D.A., 2008. Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol 39, 584-590.

Brightling, C.E., Monteiro, W., Ward, R., Parker, D., Morgan, M.D., Wardlaw, A.J., Pavord, I.D., 2000. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 356, 1480-1485.

Broadley, K.J., 2006. Beta-adrenoceptor responses of the airways: for better or worse? Eur J Pharmacol 533, 15-27.

Buhling, F., Lieder, N., Kuhlmann, U.C., Waldburg, N., Welte, T., 2007. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med 101, 2386-2394.

Butchers, P.R., Vardey, C.J., Johnson, M., 1991. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 104, 672-676.

Capelli, A., Lusuardi, M., Carli, S., Zaccaria, S., Trombetta, N., Donner, C.F., 1993. In vitro effect of beta 2-agonists on bacterial killing and superoxide anion (O2-) release from alveolar macrophages of patients with chronic bronchitis. Chest 104, 481-486.

Cataldo, D., Munaut, C., Noel, A., Frankenne, F., Bartsch, P., Foidart, J.M., Louis, R., 2000. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 123, 259-267.

Cavarra, E., Bartalesi, B., Lucattelli, M., Fineschi, S., Lunghi, B., Gambelli, F., Ortiz, L.A., Martorana, P.A., Lungarella, G., 2001. Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med 164, 886-890.

Cazzola, M., Dahl, R., 2004. Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD. Chest 126, 220-237.

Cazzola, M., Matera, M.G., 2008. Novel long-acting bronchodilators for COPD and asthma. Br J Pharmacol 155, 291-299.

Cazzola, M., Tashkin, D.P., 2009. Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function. COPD 6, 404-415.

Chen, Y., Hanaoka, M., Chen, P., Droma, Y., Voelkel, N.F., Kubo, K., 2009. Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. Am J Physiol Lung Cell Mol Physiol 296, L648-656.

Chiu, J.C., Hsu, J.Y., Fu, L.S., Chu, J.J., Chi, C.S., 2007. Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells. J Microbiol Immunol Infect 40, 388-394.

Choe, K.H., Taraseviciene-Stewart, L., Scerbavicius, R., Gera, L., Tuder, R.M., Voelkel, N.F., 2003. Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. Am J Respir Crit Care Med 167, 1516-1521.

Chorley, B.N., Li, Y., Fang, S., Park, J.A., Adler, K.B., 2006. (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS. Am J Respir Cell Mol Biol 34, 119-127.

Chua, F., Laurent, G.J., 2006. Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc 3, 424-427.

Chung, K.F., Caramori, G., Adcock, I.M., 2009. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. European journal of clinical pharmacology 65, 853-871.

Churg, A., Wang, R., Wang, X., Onnervik, P.O., Thim, K., Wright, J.L., 2007. Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs. Thorax 62, 706-713.

Churg, A., Wang, R.D., Tai, H., Wang, X., Xie, C., Wright, J.L., 2004. Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 170, 492-498.

Churg, A., Wang, R.D., Xie, C., Wright, J.L., 2003. alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 168, 199-207.

Churg, A., Wright, J.L., 2007. Animal models of cigarette smoke-induced chronic obstructive lung disease. Contrib Microbiol 14, 113-125.

Churg, A., Zhou, S., Wang, X., Wang, R., Wright, J.L., 2009. The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling. Am J Respir Cell Mol Biol 40, 482-490.

Confalonieri, M., Mainardi, E., Della Porta, R., Bernorio, S., Gandola, L., Beghe, B., Spanevello, A., 1998. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 53, 583-585.

Corbel, M., Belleguic, C., Boichot, E., Lagente, V., 2002. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell biology and toxicology 18, 51-61.

Corbel, M., Boichot, E., Lagente, V., 2000. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury. Braz J Med Biol Res 33, 749-754.

Corbel, M., Lagente, V., Theret, N., Germain, N., Clement, B., Boichot, E., 1999. Comparative effects of betamethasone, cyclosporin and nedocromil sodium in acute pulmonary inflammation and metalloproteinase activities in bronchoalveolar lavage fluid from mice exposed to lipopolysaccharide. Pulm Pharmacol Ther 12, 165-171.

Corbel, M., Lanchou, J., Germain, N., Malledant, Y., Boichot, E., Lagente, V., 2001. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice. Eur J Pharmacol 426, 113-121.

Corhay, J.L., Henket, M., Nguyen, D., Duysinx, B., Sele, J., Louis, R., 2009. Leukotriene B4 contributes to exhaled breath condensate and sputum neutrophil chemotaxis in COPD. Chest 136, 1047-1054.

Couillin, I., Vasseur, V., Charron, S., Gasse, P., Tavernier, M., Guillet, J., Lagente, V., Fick, L., Jacobs, M., Coelho, F.R., Moser, R., Ryffel, B., 2009. IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol 183, 8195-8202.

Cui, Y.Y., Zhu, L., Wang, H., Advenier, C., Chen, H.Z., Devillier, P., 2008. Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux. Life Sci 82, 949-955.

Culpitt, S.V., Maziak, W., Loukidis, S., Nightingale, J.A., Matthews, J.L., Barnes, P.J., 1999. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160, 1635-1639.

D'Armiento, J., Dalal, S.S., Okada, Y., Berg, R.A., Chada, K., 1992. Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema. Cell 71, 955-961.

D'Urzo, A.D., De Salvo, M.C., Ramirez-Rivera, A., Almeida, J., Sichletidis, L., Rapatz, G., Kottakis, J., 2001. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. Chest 119, 1347-1356.

de Oliveira Martins, J., Meyer-Pflug, A.R., Alba-Loureiro, T.C., Melbostad, H., Costa da Cruz, J.W., Coimbra, R., Curi, R., Sannomiya, P., 2006. Modulation of lipopolysaccharide-induced acute lung inflammation: Role of insulin. Shock 25, 260-266.

Demedts, I.K., Brusselle, G.G., Bracke, K.R., Vermaelen, K.Y., Pauwels, R.A., 2005. Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol 5, 257-263.

Demedts, I.K., Morel-Montero, A., Lebecque, S., Pacheco, Y., Cataldo, D., Joos, G.F., Pauwels, R.A., Brusselle, G.G., 2006. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax 61, 196-201.

Deshmukh, H.S., McLachlan, A., Atkinson, J.J., Hardie, W.D., Korfhagen, T.R., Dietsch, M., Liu, Y., Di, P.Y., Wesselkamper, S.C., Borchers, M.T., Leikauf, G.D., 2009. Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am J Respir Crit Care Med 180, 834-845.

Deshmukh, H.S., Shaver, C., Case, L.M., Dietsch, M., Wesselkamper, S.C., Hardie, W.D., Korfhagen, T.R., Corradi, M., Nadel, J.A., Borchers, M.T., Leikauf, G.D., 2008. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Respir Cell Mol Biol 38, 446-454.

Di Marco, F., Verga, M., Santus, P., Morelli, N., Cazzola, M., Centanni, S., 2006. Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study. Respir Med 100, 1925-1932.

Donnelly, L.E., Tudhope, S.J., Fenwick, P.S., Barnes, P.J., 2010. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. Eur Respir J 36, 178-186.

Donohue, J.F., 2005. Combination therapy for chronic obstructive pulmonary disease: clinical aspects. Proc Am Thorac Soc 2, 272-281; discussion 290-271.

Donohue, J.F., Hanania, N.A., Sciarappa, K.A., Goodwin, E., Grogan, D.R., Baumgartner, R.A., Hanrahan, J.P., 2008. Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. Therapeutic advances in respiratory disease 2, 37-48.

Donohue, J.F., Menjoge, S., Kesten, S., 2003. Tolerance to bronchodilating effects of salmeterol in COPD. Respir Med 97, 1014-1020.

Drummond, M.B., Dasenbrook, E.C., Pitz, M.W., Murphy, D.J., Fan, E., 2008. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 300, 2407-2416.

Ezeamuzie, C.I., al-Hage, M., 1998. Differential effects of salbutamol and salmeterol on human eosinophil responses. J Pharmacol Exp Ther 284, 25-31.

Farina, J., Ribas, B., Fernandez-Acenero, M.J., Gascon, C., 1996. Pulmonary toxicity of cadmium in rats: a histologic and ultrasound study. Gen Diagn Pathol 141, 365-369.

Fievez, L., Kirschvink, N., Belleflamme, M., Lagente, V., Gustin, P., 2006. Effects of the MMP inhibitor GM-6001 on emphysema development, inflammation and MMPs activity induced by cadmium in rats. Fundam Clin Pharmacol 20, 194.

Fievez, L., Kirschvink, N., Zhang, W.H., Lagente, V., Lekeux, P., Bureau, F., Gustin, P., 2009. Effects of betamethasone on inflammation and emphysema induced by cadmium nebulisation in rats. Eur J Pharmacol 606, 210-214.

Finlay, G.A., Russell, K.J., McMahon, K.J., D'Arcy E, M., Masterson, J.B., FitzGerald, M.X., O'Connor, C.M., 1997. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 52, 502-506.

Fligiel, S.E., Standiford, T., Fligiel, H.M., Tashkin, D., Strieter, R.M., Warner, R.L., Johnson, K.J., Varani, J., 2006. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum Pathol 37, 422-430.

Foronjy, R., Nkyimbeng, T., Wallace, A., Thankachen, J., Lemaitre, V., D'Armiento, J., 2008. Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. Am J Physiol Lung Cell Mol Physiol 294, L1149-1157.

Friedman, M., 1997. Combined bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respirology 2 Suppl 1, S19-23.

Fujita, J., Nelson, N.L., Daughton, D.M., Dobry, C.A., Spurzem, J.R., Irino, S., Rennard, S.I., 1990. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. Am Rev Respir Dis 142, 57-62.

Gabrijelcic, J., Casas, A., Rabinovich, R.A., Roca, J., Barbera, J.A., Chung, K.F., Rodriguez-Roisin, R., 2004. Formoterol protects against platelet-activating factor-induced effects in asthma. Eur Respir J 23, 71-75.

Gavaldà, A., Miralpeix, M., Ramos, I., Otal, R., Carreño C, Viñals M Doménech, T., Carcasona, C., Reyes, B., Vilella, D., Gras, J., Cortijo, J., Morcillo, E., Llenas, J., Ryder, H., Beleta, J., 2009. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile. J Pharmacol Exp Ther 331, 740-751.

Gavett, S.H., Oberdorster, G., 1994. Cadmium chloride and cadmium metallothionein-induced pulmonary injury and recruitment of polymorphonuclear leukocytes. Exp Lung Res 20, 517-537.

Gentilini, G., Grazia di Bello, M., Raspanti, S., Bindi, D., Mugnai, S., Zilletti, L., 1994. Salmeterol inhibits anaphylactic histamine release from guinea-pig isolated mast cells. J Pharm Pharmacol 46, 76-77.

Giebelen, I.A., Leendertse, M., Dessing, M.C., Meijers, J.C., Levi, M., Draing, C., von Aulock, S., van der Poll, T., 2008. Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulation. Am J Respir Cell Mol Biol 39, 373-379.

Gosens, R., Bos, I.S., Zaagsma, J., Meurs, H., 2005. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 171, 1096-1102.

Gosens, R., Rieks, D., Meurs, H., Ninaber, D.K., Rabe, K.F., Nanninga, J., Kolahian, S., Halayko, A.J., Hiemstra, P.S., Zuyderduyn, S., 2009. Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J 34, 1436-1443.

Gosens, R., Zaagsma, J., Meurs, H., Halayko, A.J., 2006. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 7, 73.

Grasseschi, R.M., Ramaswamy, R.B., Levine, D.J., Klaassen, C.D., Wesselius, L.J., 2003. Cadmium accumulation and detoxification by alveolar macrophages of cigarette smokers. Chest 124, 1924-1928.

Gross, N.J., Co, E., Skorodin, M.S., 1989. Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects. Chest 96, 984-987.

Gross, P., Pfitzer, E.A., Tolker, E., Babyak, M.A., Kaschak, M., 1965. Experimental Emphysema: Its Production with Papain in Normal and Silicotic Rats. Arch Environ Health 11, 50-58.

Gueders, M.M., Foidart, J.M., Noel, A., Cataldo, D.D., 2006. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 533, 133-144.

Gwilt, C.R., Donnelly, L.E., Rogers, D.F., 2007. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 115, 208-222.

Haag, S., Matthiesen, S., Juergens, U.R., Racke, K., 2008. Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J 32, 555-562.

Hanania, N.A., 2008. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Pulm Pharmacol Ther 21, 540-550.

Hanania, N.A., Boota, A., Kerwin, E., Tomlinson, L., Denis-Mize, K., 2009. Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. Drugs 69, 1205-1216.

Hanania, N.A., Donohue, J.F., 2007. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Proc Am Thorac Soc 4, 526-534.

Hanania, N.A., Moore, R.H., 2004. Anti-inflammatory activities of beta2-agonists. Curr Drug Targets Inflamm Allergy 3, 271-277.

Haney, S., Hancox, R.J., 2005. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med 99, 566-571.

Harkema, J.R., Hotchkiss, J.A., 1993. Ozone- and endotoxin-induced mucous cell metaplasias in rat airway epithelium: novel animal models to study toxicant-induced epithelial transformation in airways. Toxicol Lett 68, 251-263.

Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., Shapiro, S.D., 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (New York, N.Y 277, 2002-2004.

Hogg, J.C., 2004. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364, 709-721.

Hogg, J.C., Chu, F., Utokaparch, S., Woods, R., Elliott, W.M., Buzatu, L., Cherniack, R.M., Rogers, R.M., Sciurba, F.C., Coxson, H.O., Pare, P.D., 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350, 2645-2653.

Hoidal, J.R., Niewoehner, D.E., Rao, N.V., Hibbs, M.S., 1985. The role of neutrophils in the development of cadmium chloride-induced emphysema in lathyrogen-fed hamsters. Am J Pathol 120, 22-29.

Holgate, S.T., 2008. Pathogenesis of asthma. Clin Exp Allergy 38, 872-897.

Hoshino, M., Takahashi, M., Takai, Y., Sim, J., 1999. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 104, 356-363.

Hsu, J.Y., Perng, R.P., Lu, J.Y., Wu, C.P., Huang, M.S., Luh, K.T., Yang, P.C., 2006. Double-blind randomized parallel group study comparing the efficacy and safety of tiotropium and ipratropium in the treatment of COPD patients in Taiwan. Journal of the Formosan Medical Association = Taiwan yi zhi 105, 708-714.

Ikenouchi, T., Kume, H., Oguma, T., Makino, Y., Shiraki, A., Ito, Y., Shimokata, K., 2008. Role of Ca(2+) mobilization in desensitization of beta-adrenoceptors by platelet-derived growth factor in airway smooth muscle. Eur J Pharmacol 591, 259-265.

Inoue, H., Aizawa, H., Matsumoto, K., Shigyo, M., Takata, S., Hara, M., Hara, N., 1997. Effect of beta 2-agonists on histamine-induced airway microvascular leakage in ozone-exposed guinea pigs. Am J Respir Crit Care Med 156, 723-727.

Ioachimescu, O.C., Stoller, J.K., 2005. A review of alpha-1 antitrypsin deficiency. Copd 2, 263-275.

Jeffery, P.K., Venge, P., Gizycki, M.J., Egerod, I., Dahl, R., Faurschou, P., 2002. Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study. Eur Respir J 20, 1378-1385.

Johnson, M., 2002. Effects of beta2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol 110, S282-290.

Johnson, M., 2004. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 1, 200-206.

Johnson, M., 2006. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 117, 18-24; quiz 25.

Johnson, M., Rennard, S., 2001. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. Chest 120, 258-270.

Jones, P.W., 2009. Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice? Am J Respir Crit Care Med 180, 689-690.

База данных защищена авторским правом © 2016
звярнуцца да адміністрацыі

    Галоўная старонка